Best Telehealth Providers for Zepbound in 2026
Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
The Ranking
SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
Full review →
Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.
Full review →
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Editor’s take: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.
Full review →
Found
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Editor’s take: One of the more coaching-forward GLP-1 telehealth options. Pricing tiers can confuse first-time buyers; verify the cancellation terms before subscribing. Pricing tiers can confuse first-time buyers; verify the cancellation policy before subscribing. If you want the lowest possible cost for compounded GLP-1 without coaching, Trimi or HealthRx will be significantly cheaper.
Full review →
Strut Health
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
Editor’s take: An efficient generalist. If you want depth in any one category, you'll find better. If you want breadth and a low management overhead, Strut Health is on the shortlist.
Full review →
Zealthy
Online GLP-1 care centered on insurance navigation, brand-name prescriptions and cash-pay semaglutide options.
Editor’s take: Zealthy pairs online weight-management care with insurance-navigation support and a cash-pay path. Its displayed $25–$151 monthly range is useful for comparison, but the endpoints carry different insurance and commitment conditions; confirm the exact medication, covered benefit, recurring fee, dose and renewal terms before paying.
Full review →
FeelGood
Personalized GLP-1 program with injectable and oral options, 24/7 clinician support, and a money-back guarantee from $149/mo.
Editor’s take: A well-rounded compounded GLP-1 program with one of the most comprehensive support offerings in the category. The 24/7 unlimited support and money-back guarantee stand out. Oral tablet option is a plus for needle-averse patients.
Full review →
AltRx
Budget-first compounded GLP-1 clinic with a low advertised entry price ($89/mo semaglutide), transparent pricing, and optional brand-name GLP-1 access.
Editor’s take: A competitive budget-tier GLP-1 option with a low promotional entry price. Readers should note that the $89/mo rate is a first-month promotional price; standard pricing starts at $159/mo. The BNPL option and brand-name access add flexibility.
Full review →2026 Price Comparison. Published Price Terms
Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.
Recorded price-check dates: 17 June 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
4 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| SkinnyRxBest Overall | Lower listed rate$149/mo | Higher listed rate$249/mo | PharmacyBrand Rx | 4.8/5 5,335 reviews 17 June 2026 | Go SkinnyRxRead full review |
| Found Health | Lower listed rate$129/mo | Higher listed rate$349/mo | PharmacyBrand Rx | 3.7/5 729 reviews 17 June 2026 | Go FoundRead full review |
| FeelGood | Lower listed rate$149/mo | Higher listed rate$349/mo | PharmacyBrand Rx | 4.5/5 17 June 2026 | Go FeelGoodRead full review |
| Shed Rx | Lower listed rate$199/mo | Higher listed rate$449/mo | PharmacyBrand Rx | 4.7/5 956 reviews 17 June 2026 | Go Shed RxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
What to know before choosing
Zepbound (tirzepatide, Eli Lilly) is the only FDA-approved dual GIP/GLP-1 receptor agonist for chronic weight management. In the pivotal SURMOUNT-1 trial (NEJM 2022), participants on the 15 mg dose lost a mean of 20.9% of body weight at 72 weeks. Several telehealth platforms now prescribe brand-name Zepbound without an in-person visit. We compared them on pricing, insurance navigation, clinical oversight, and shipping reliability.
Zepbound (tirzepatide) is the FDA-approved injectable GLP-1/GIP dual agonist for chronic weight management, with the highest efficacy data in the class. The SURMOUNT-1 trial (NEJM 2022) showed 20.9% mean weight loss at the 15 mg dose over 72 weeks — the largest pharmacological weight-loss result ever recorded in a Phase 3 trial at the time of publication.
Accessing brand-name Zepbound through telehealth requires a licensed prescriber and a pharmacy that stocks it. List price without insurance is approximately $1,060/month with Eli Lilly's direct-to-patient programme. The best telehealth platforms that prescribe Zepbound have a clear insurance navigation pathway, offer Lilly's savings programmes, and include a licensed physician in the prescribing workflow.
We evaluated the platforms in our network that actively prescribe brand-name Zepbound (not compounded tirzepatide) and ranked them on prescribing access, insurance navigation support, pricing transparency, and clinical oversight quality.
Methodology
Only platforms that prescribe FDA-approved Zepbound (not compounded tirzepatide) are included. Ranked on pricing transparency, insurance support, clinical oversight quality, and Trustpilot score.
Getting Zepbound Through Telehealth: The Tirzepatide Advantage
Zepbound (tirzepatide) is the newest FDA-approved weight management medication and has shown the highest mean weight loss of any approved pharmacotherapy. Here is what distinguishes it from semaglutide and what to expect from telehealth prescribing.
The Dual Mechanism: Why Tirzepatide Outperforms Semaglutide
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. Semaglutide activates only the GLP-1 receptor. The additive effect of dual agonism appears to produce greater weight loss: SURMOUNT-1 showed 20.9% mean weight loss at the 15 mg dose versus STEP 1's 14.9% for semaglutide.
Head-to-head comparison data (SURMOUNT-5) confirmed tirzepatide's superiority over semaglutide for weight loss. The tradeoff is that tirzepatide is newer, has less long-term safety data, and is more expensive.
Insurance Coverage and Savings Programs
Zepbound's list price is approximately $1,060/month. Eli Lilly's LillyDirect savings program offers Zepbound at $550/month for uninsured patients and $25/month for commercially insured patients with coverage. Commercial insurance coverage is expanding but still inconsistent — many plans cover Ozempic for diabetes but not Zepbound for weight management.
Telehealth clinics that actively help patients navigate Eli Lilly's savings programs and prior authorization processes are providing meaningful value. Clinics that simply write the prescription and leave insurance navigation to the patient are offering less complete care.
Who Is a Good Candidate for Zepbound vs Wegovy
For patients who have not tried a GLP-1 before, either Wegovy or Zepbound is a reasonable starting point. For patients who have tried semaglutide and achieved less than 10% weight loss, switching to tirzepatide is clinically reasonable — the dual mechanism may produce a better response.
Patients with type 2 diabetes who are also managing blood sugar should note that tirzepatide is approved for diabetes as Mounjaro — the same molecule at the same doses. The diabetes indication may improve insurance coverage.
Zepbound is the most effective FDA-approved weight management medication currently available. The clinics in our top tier above prescribe it with proper titration support and help patients navigate the savings programs that make it affordable.
What the Studies Actually Show
Zepbound contains tirzepatide, the active ingredient studied in the SURMOUNT programme. The figures below are from the pivotal SURMOUNT-1 and SURMOUNT-2 trials.
| Endpoint | Finding |
|---|---|
| Mean weight loss (SURMOUNT-1, 72 weeks, 15 mg)1 | −20.9% body weight vs −3.1% placebo in adults with obesity without diabetes |
| Mean weight loss with T2D (SURMOUNT-2, 72 weeks, 15 mg)2 | −14.7% body weight in adults with type 2 diabetes |
| Sleep apnea (SURMOUNT-OSA)3 | Tirzepatide reduced apnea-hypopnea index (AHI) by ~25–29 events/hour vs placebo at 52 weeks; FDA-approved labeling for moderate-to-severe OSA in obesity |
| GI side effects (FDA prescribing information)4 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥5%, constipation ≥5% |
Frequently Asked Questions
How much does Zepbound cost through telehealth?
Without insurance, Zepbound typically costs $1,060-$1,400 per month at retail. Eli Lilly's LillyDirect savings programme can reduce costs to $550/month for cash-pay patients. With commercial insurance and prior authorisation, out-of-pocket costs can be as low as $25/month for eligible patients.
Is Zepbound the same as Mounjaro?
Yes and no. Both contain tirzepatide as the active ingredient. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management (and sleep apnea in obesity). The doses and injection devices are identical, but the indications and insurance coverage differ.
Is Zepbound better than Wegovy?
In the SURMOUNT-1 trial (NEJM 2022), tirzepatide 15 mg achieved 20.9% mean weight loss vs 14.9% for semaglutide 2.4 mg in the STEP 1 trial (NEJM 2021). These are separate trials with different populations; no direct head-to-head trial between Zepbound and Wegovy has been published. Tirzepatide's dual GIP/GLP-1 mechanism appears to produce greater weight loss on average, but individual responses vary.
Can I get Zepbound online without an in-person visit?
Yes. All platforms on this list conduct a clinical evaluation asynchronously or via video, which satisfies the prescribing requirements for Zepbound in most US states.
- SURMOUNT-1 — NEJM 2022 · Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387:205–216.
- SURMOUNT-2 — Lancet 2023 · Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2023;402(10402):613–626.
- SURMOUNT-OSA — NEJM 2024 · Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 2024;391:1193–1205.
- SURPASS — program summary · Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med 2021;385:503–515.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.